Edwards Larry Todd (CIK 1994805) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-25). Recent activity: Buy ORKA (100,000 shares), Buy ARQT (30,000 shares), Sell ARQT (3,584 shares), Sell ARQT (103 shares), Sell ARQT (2,052 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Oruka Therapeutics, Inc. (ORKA) | Chief Commercial Officer | Buy | 100,000 | $0 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Commercial Officer | Buy | 30,000 | $0 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Commercial Officer | Sell | 3,584 | $90,173 |
| 2026-03-03 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Commercial Officer | Sell | 103 | $2,669 |
| 2026-02-04 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP Chief Commercial Officer | Sell | 2,052 | $52,326 |
| 2025-11-10 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP Chief Commercial Officer | Sell | 29,131 | $732,936 |
| 2025-10-06 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP Chief Commercial Officer | Sell | 4,207 | $84,098 |
| 2025-10-06 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP Chief Commercial Officer | Sell | 297 | $6,172 |
| 2025-05-20 | Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP Chief Commercial Officer | Sell | 7,451 | $104,836 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25